Pediatr. praxi. 2014;15(1):16-21

Reasonable treatment in children with respiratory infections

MUDr.Hana Roháčová, Ph.D.
Infekční klinika, Nemocnice Na Bulovce, Praha

Infections of the respiratory system constitute some of the most common childhood illnesses throughout the year. The number of

infections increases mainly in the colder months wherein children fall ill several times over the course of several months. These are

mainly mild upper respiratory cases. However there are cases that are not so trivial. These are mainly lower respiratory infections and

even inner ear complaints which can have a severe course and can be accompanied by a range of complication that may even lead

to long-term consequences. The vast majority of respiratory infections are of viral origin; therefore, their treatment is symptomatic.

Nevertheless, some illnesses are bacterial. These are either primary bacterial infections or arise as a complication of viral infection.

The appropriate treatment is then antibacterial. However, given the increasing incidence of resistance and possible complications

during antibacterial treatment, particularly with the current proliferation of Clostridium difficile enterocolitis (currently affecting

mainly adult patients), it is necessary to select an antibacterial agent with the narrowest spectrum and with a degree of certainty as

to the microbial cause of the infection.

Keywords: respiratory infections, aetiological agents of respiratory tract infections, antibiotic treatment, vaccination

Published: February 15, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Roháčová H. Reasonable treatment in children with respiratory infections. Pediatr. praxi. 2014;15(1):16-21.
Download citation

References

  1. Gill JM, Fleishut, et al. Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study. Farm Med 2006; 38(5): 349-354.
  2. Beneš J. Infekce dýchacích cest, in Beneš J. Infekční lékařství. Praha: Galén 2009.
  3. Žemličková H. Antibiotická rezistence bakteriálních původců nejčastějších komunitních pneumonií v České republice. První linie 2012; 2(3): 13-15.
  4. Neumann MI, Harper MB. Evaluation of rapid urine antigen assay for the detection of invasive pneumococcal disease in children. Pediatrics 2003; 112: 1279-1282. Go to original source... Go to PubMed...
  5. Saha SK, Darmstadt GL, et al. Rapid diagnosis of pneumococcal meningitis: implication of treatment and measuring disease burden. Pediatr. Infect Dis J 2005; 24(12): 1093-1098. Go to original source... Go to PubMed...
  6. Serpil E, Alper E, et al. Validation of urinary antigen test for Streptococcus pneumoniae in patiens with pneumococcal pneumonia. Jpn. J. Infect. Dis., 2006; 59: 388-390.
  7. Houšťková H, Dedek V, et al. Pneumokokové infekce v pediatrické praxi. Pediatr. praxi, 2008; 1: 6-11.
  8. Horová B. Chlamydiové infekce: příznaky, diagnostika, interpretace výsledků a léčba. Medicína pro praxi, 2011; 8(12): 528-531.
  9. Hupková H, Urbancíková I, Bazárová K, et al. Two cases of severe invasive infections in children caused by Streptococcus pneumoniae serotype 14-case report. Folia Microbiol 2009; 54(6): 563-565. Go to original source... Go to PubMed...
  10. Shoda T, Isozaki A. A case of empyema in a previously healthy child caused by Streptococcus pneumoniae serotype 1, Kansenshogaku Zasshi, 2009; 83(6): 665-668. Go to original source... Go to PubMed...
  11. Copelovitch L, Kaplan BS. Streptococcus pneumoniae-associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics, 2010; 125(1): 174-182. Go to original source... Go to PubMed...
  12. Lukkarinen H, Marttila H, Perttilä J, et al. Group A streptococcal pneumonia. Duodecim 2012; 128(8): 825-829. Go to PubMed...
  13. Guidi R, Osimani P, Azzari C, et al. Severe necrotizing pneumonia complicating influenza A (H1N1): the role of immunologic interaction. Int J Immunopathol Pharmacol. 2011; 24(4): 1093-1097. Go to original source... Go to PubMed...
  14. Ambrozova H, Maresova V, Fajt M, et al. The first of fatal pneumonia cause by Panton-Valentine leukocidin-producing Staphyloccocus aureus in an infant in the Czech Republic. Folia Microbiol, Published online 17 October 2012.
  15. Gentile A, Bazán V. Prevention of pneumococcal disease through vaccination. Vaccine 2011; 14; 29(Suppl 3): C15-25. Go to original source... Go to PubMed...
  16. Black S. Effectiveness of the pneumococcal conjugate vaccine for pneumonia in children. Pediatr Infect Dis J. 2011; 30(10): 917-918. Go to original source... Go to PubMed...
  17. Tregnaghi, et al. XIV SLIPE, Punta Cana, May 2011.
  18. Tregnaghi, et al. 29th ESPID, The Hague, June 2011.
  19. Havlíčková M. Chřipka-preventabilní onemocnění. První linie 2012; 2(4): 14-15.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.